1. Home
  2. |Insights
  3. |Janssen Biotech Unable To Rewrite History and Save Remicade Patent

Janssen Biotech Unable To Rewrite History and Save Remicade Patent

Client Alert | less than 1 min read | 01.25.18

Insights

Client Alert | 4 min read | 04.02.26

FTC Announces New Health Care Task Force

In a development likely to ramp up regulatory pressure on an industry already under significant federal scrutiny, Federal Trade Commission (FTC) Chairman Andrew Ferguson recently directed leaders across his agency to launch a team dedicated to cooperatively advancing enforcement and advocacy activities relevant to health care....